Top Markets
#1 DogBull DogBull +104.74%
#2 MarsCoin MarsCoin +51.61%
#3 Siacoin Siacoin +49.65%
#4 ADO Protocol ADO Protocol +46.18%
#5 UnifAI Network UnifAI Network +44.48%
#6 Magma Finance Magma Finance +23.10%
#7 Useless Coin Useless Coin +22.15%
#8 Ontology Gas Ontology Gas +20.65%
#9 Cash Cat Cash Cat +17.68%
#10 Apertum Apertum +13.54%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Genetron Holdings Limited Genetron Holdings Limited

Genetron Holdings Limited

GTH
Classement en actions #15209
Genetron Holdings Limited (GTH) is a precision oncology company that... Genetron Holdings Limited (GTH) is a precision oncology company that specializes in cancer molecular profiling, utilizing advanced molecular biology and data science to enhance cancer treatment. The company delivers a range of services, including diagnosis, monitoring, and early screening, primarily through its proprietary laboratory-developed tests. Its product offerings encompass a variety of in-vitro diagnostic (IVD) solutions. These include the 8-gene lung cancer assay, an IVD product for lung cancer detection; the Genetron 3D biochip reading instrument; and the Genetron S5, a semiconductor-based next-generation sequencing (NGS) system that identifies nucleotides by detecting pH changes. Other key products are the Genetron Chef System, the production-scale Genetron S2000 sequencing platform, and Onco PanScan, a genomic profiling service for diverse solid tumors. Moreover, Genetron provides specialized assays such as the IDH1 and TERT gene assays for glioma, a fundamental thyroid assay for thyroid tumors, a platelet-derived growth factor receptor alpha assay for GIST cancer, and HCCscan, a qPCR-based assay designed to detect hepatocellular carcinoma. Beyond its direct services and products, the company offers genomics research and clinical development services, often in collaboration with biopharmaceutical companies globally. Genetron has also established a strategic partnership with JD Health to develop holistic solutions for comprehensive cancer management. The company was founded in 2015 and has its headquarters in Beijing, People's Republic of China.
Prix de l'action
$4.03
Dernière synchronisation: 2024-03-28
Capitalisation boursière
$366.11M
Changement (1 jour)
0.25%
Changement (1 an)
0.00%
Pays
CN
Échange Genetron Holdings Limited (GTH)

Catégorie

Healthcare
Historique du prix de l'action pour Genetron Holdings Limited (GTH)
Prix de clôture le plus élevé : $3.93 le 2024-03-01

Prix de clôture le plus bas : $43.02 le 2020-06-01
Historique du prix de l'action de Genetron Holdings Limited de 2020 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 6.72%
2023 21.09%
2022 -85.89%
2021 -45.87%
2020 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $600.47 21.87%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $206.90 0.52%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $22.13 41.40%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $324.57 92.91%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $545.33 -15.73%
US